A-Z Index
Image Cart
              

 Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members

Revision Bulletin

Etodolac Extended-Release Tablets Monograph

Posting Date: January 30, 2009
Official Date: March 1, 2009
Expert Committee: Biopharmaceutics
Transfers to Accelerated Revision History section: June 1, 2009


In accordance with the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee has approved the Etodolac Extended-Release Tablets Monograph Revision Bulletin. The Revision Bulletin adds a Dissolution test.

The Etodolac Extended-Release Tablets Monograph Revision Bulletin supersedes the monograph in USP 32–NF 27 until it is printed in the USP 32–NF 27 Second Supplement, which will be released June 1, 2009.

Should you have any questions, please contact Margareth Marques, Ph.D. (301-816-8106 or ).

Download the Etodolac Extended-Release Tablets Monograph  (30KB)

What's New

Changes to the Dissolution Performance Verification Test (11/20/09)

PF 35(6) Errata (10/30/09)

New official Text for October: 15 Revisions Bulletins (10/30/09)

Pending Standards for the month of October (10/30/09)

PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09)

Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09)

Elemental Impurities Hot Topics information updated (10/13/09)

General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09)

Heparin Hot Topics information updated (10/02/09)

PF Redesign

Related Resources